Cargando…
C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia
Monocytic leukemia-associated antigen-34 (MLAA-34) is a novel monocytic leukemia-associated antigen and a candidate oncogene. The aim of the present study was to investigate the involvement of the MLAA-34 gene in acute myeloid leukemia (AML). MLAA-34 expression level, chromosome location, gene copy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494830/ https://www.ncbi.nlm.nih.gov/pubmed/28693135 http://dx.doi.org/10.3892/ol.2017.6110 |
_version_ | 1783247728691642368 |
---|---|
author | Lei, Bo Chen, Yinxia He, Aili Luo, Jing Zhang, Pengyu Zhou, Fuling Liu, Jie Meng, Xin Wang, Jing Zhang, Wanggang |
author_facet | Lei, Bo Chen, Yinxia He, Aili Luo, Jing Zhang, Pengyu Zhou, Fuling Liu, Jie Meng, Xin Wang, Jing Zhang, Wanggang |
author_sort | Lei, Bo |
collection | PubMed |
description | Monocytic leukemia-associated antigen-34 (MLAA-34) is a novel monocytic leukemia-associated antigen and a candidate oncogene. The aim of the present study was to investigate the involvement of the MLAA-34 gene in acute myeloid leukemia (AML). MLAA-34 expression level, chromosome location, gene copy number and single nucleotide polymorphisms (SNPs) of 40 patients with AML and 5 healthy volunteers were analyzed by reverse transcription-polymerase chain reaction, fluorescence in situ hybridization and DNA sequencing. The effects of MLAA-34 mutation on overall survival (OS) and progression-free survival (PFS) of patients with AML were also analyzed. MLAA-34 was significantly upregulated in patients with AML when compared with volunteer controls, and this upregulation was associated with a C59T SNP site located in the second exon of MLAA-34. MLAA-34 was mapped to 13q14.2 and no translocation was observed in patients with AML. In addition, this SNP site is affinitive to the well-known molecular markers of AML, including Fms-like tyrosine kinase 3 and DNA methyltransferase 3A, as well as extramedullary lesions, periphery leukocyte numbers, remission and cytogenetic abnormalities of patients with AML. Patients with AML with MLAA-34 C59T mutations had significantly shorter OS and PFS times compared with that of patients without C59T mutations. The present findings indicated that the MLAA-34 C59T mutation was a high-risk factor for recurrence of AML, and may be a candidate target for AML therapy. |
format | Online Article Text |
id | pubmed-5494830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-54948302017-07-07 C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia Lei, Bo Chen, Yinxia He, Aili Luo, Jing Zhang, Pengyu Zhou, Fuling Liu, Jie Meng, Xin Wang, Jing Zhang, Wanggang Oncol Lett Articles Monocytic leukemia-associated antigen-34 (MLAA-34) is a novel monocytic leukemia-associated antigen and a candidate oncogene. The aim of the present study was to investigate the involvement of the MLAA-34 gene in acute myeloid leukemia (AML). MLAA-34 expression level, chromosome location, gene copy number and single nucleotide polymorphisms (SNPs) of 40 patients with AML and 5 healthy volunteers were analyzed by reverse transcription-polymerase chain reaction, fluorescence in situ hybridization and DNA sequencing. The effects of MLAA-34 mutation on overall survival (OS) and progression-free survival (PFS) of patients with AML were also analyzed. MLAA-34 was significantly upregulated in patients with AML when compared with volunteer controls, and this upregulation was associated with a C59T SNP site located in the second exon of MLAA-34. MLAA-34 was mapped to 13q14.2 and no translocation was observed in patients with AML. In addition, this SNP site is affinitive to the well-known molecular markers of AML, including Fms-like tyrosine kinase 3 and DNA methyltransferase 3A, as well as extramedullary lesions, periphery leukocyte numbers, remission and cytogenetic abnormalities of patients with AML. Patients with AML with MLAA-34 C59T mutations had significantly shorter OS and PFS times compared with that of patients without C59T mutations. The present findings indicated that the MLAA-34 C59T mutation was a high-risk factor for recurrence of AML, and may be a candidate target for AML therapy. D.A. Spandidos 2017-07 2017-05-02 /pmc/articles/PMC5494830/ /pubmed/28693135 http://dx.doi.org/10.3892/ol.2017.6110 Text en Copyright: © Lei et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Lei, Bo Chen, Yinxia He, Aili Luo, Jing Zhang, Pengyu Zhou, Fuling Liu, Jie Meng, Xin Wang, Jing Zhang, Wanggang C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia |
title | C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia |
title_full | C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia |
title_fullStr | C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia |
title_full_unstemmed | C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia |
title_short | C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia |
title_sort | c59t mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494830/ https://www.ncbi.nlm.nih.gov/pubmed/28693135 http://dx.doi.org/10.3892/ol.2017.6110 |
work_keys_str_mv | AT leibo c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT chenyinxia c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT heaili c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT luojing c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT zhangpengyu c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT zhoufuling c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT liujie c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT mengxin c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT wangjing c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia AT zhangwanggang c59tmutationinexon2ofmonocyticleukemiaassociatedantigen34geneindicatesahighriskofrecurrenceofacutemyeloidleukemia |